Podcasts
Blog
Podcasts
Blog
JACC: Advances - Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
02.28.2024 -
By American College of Cardiology
Download our free app to listen on your phone
Commentary by Dr. Candice Silversides
More episodes from JACC Specialty Journals